Interference of spironolactone, canrenone, and related metabolites on two digoxin assays.

被引：0
|
作者：
Day, KR
Tamashiro, W
Nadkarni, S
Winslow, E
Weinzierl, C
机构：
[1] Beckman Coulter Inc, Brea, CA USA
[2] Beckman Coulter Inc, Chaska, MN USA
来源：
CLINICAL CHEMISTRY | 2003年 / 49卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A90 / A90
页数：1
相关论文
共 50 条
  • [21] Effect of Spironolactone, Potassium Canrenoate, and Their Common Metabolite Canrenone on Dimension Vista Digoxin Assay
    Dasgupta, Amitava
    Johnson, Myrtle J.
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2010, 24 (06) : 413 - 417
  • [22] SPIRONOLACTONE INTERFERENCE WITH DIGOXIN RADIOIMMUNOASSAY IN CIRRHOTIC-PATIENTS
    DIPIRO, JT
    COTE, JR
    DIPIRO, CR
    BUSTRACK, JA
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1980, 37 (11): : 1518 - 1521
  • [23] Aldosterone receptor blockers spironolactone and canrenone: two multivalent drugs
    Armanini, Decio
    Sabbadin, Chiara
    Dona, Gabriella
    Clari, Giulio
    Bordin, Luciana
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (07) : 909 - 912
  • [24] INTERFERENCE WITH SERUM DIGOXIN ASSAYS IN NEONATES
    LEVINE, M
    GILL, S
    SECCOMBE, DW
    PUDEK, MR
    CLINICAL PHARMACY, 1984, 3 (03): : 239 - 239
  • [25] A new enzyme-linked chemiluminescent immunosorbent digoxin assay is virtually free from interference of spironolactone, potassium canrenoate, and their common metabolite canrenone
    Dasgupta, Arnitava
    Kang, Edward
    Datta, Pradip
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2006, 20 (05) : 204 - 208
  • [26] Comparison of the Abbott Axsym® Digoxin II assay with the Stratus and the ACS:180 assays.
    Engelmayer, U
    Binder, L
    Armstrong, VW
    Nguyen, T
    Oellerich, M
    CLINICAL CHEMISTRY, 1998, 44 : A104 - A105
  • [27] Incidence of heterophile antibody interference in eight tumor marker assays.
    Preissner, CM
    Dodge, LA
    O'Kane, DJ
    Grebe, SK
    CLINICAL CHEMISTRY, 2004, 50 (06) : A81 - A81
  • [28] Detection of thyroid autoantibodies by two different assays.
    Aw, TC
    Saw, B
    Sethi, SK
    CLINICAL CHEMISTRY, 1998, 44 : A151 - A151
  • [29] REASSESSMENT OF CROSS-REACTIVITY OF SPIRONOLACTONE METABOLITES WITH 4 DIGOXIN IMMUNOASSAYS
    PLEASANTS, RA
    WILLIAMS, DM
    PORTER, RS
    GADSDEN, RH
    THERAPEUTIC DRUG MONITORING, 1989, 11 (02) : 200 - 204
  • [30] Lack of clinically significant interference by spironolactone with the AxSym digoxin II assay
    Howard, G
    Barclay, M
    Florkowski, C
    Moore, G
    Roche, A
    THERAPEUTIC DRUG MONITORING, 2003, 25 (01) : 112 - 113
12345